1 completed, 1 not yet recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow CuromeBiosciences: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of HK-660S in the Treatment of Primary Sclerosing Cholangitis HK-660S 100mg, HK-660S 200mg, Placebo - Primary Sclerosing Cholangitis (PSC) | Phase 2 | Not yet recruiting | CuromeBiosciences | 105 | 2025-08-18 | 2025-05-16 |
| Evaluation of the Safety and Efficacy of HK-660S in Patients With Primary Sclerosing Cholangitis HK-660S, Placebo - Primary Sclerosing Cholangitis | Phase 2 | Completed | CuromeBiosciences | 23 | 2021-10-28 | 2023-07-27 |
South Korea (1)
Do-hyun Park (1)